Real-time financial
intelligence.
Signal, not noise.
Real-time signals from 70+ wires — AI-summarized, analyst-supervised, on your screen seconds after the issuer presses send.
14-day free trial · $0 today · Cancel anytime before charge
Real-time wires
Adaptive cadence — 5s pre-market and after-hours, 15s during the regular session. Direct from issuer wires, no aggregator delay.
AI, analyst-supervised
Every release distilled by a frontier model and validated against rules from a working market analyst. Schema-checked before publish.
Coverage breadth
PR Newswire, GlobeNewswire, BusinessWire, EDGAR 8-Ks, Newsfile, Accesswire, gov releases (FDA, FTC, DOJ), and 60+ more.
Catalysts in context
Earnings with consensus + surprise %. Analyst upgrades flow to Ratings + Calendar. Form 4 buys, 13D stakes, shelf pricings tagged to issuer.
Every catalyst, in context.
Beats and misses land with surprise % and YoY deltas already on the card. Analyst upgrades and downgrades feed the Ratings page and its dedicated calendar. Form 4 insider buys, 13D activist stakes, shelf pricings — categorized, tagged, on a per-ticker timeline.
- Earnings with consensus + actual + surprise %
- Per-ticker watchlist with instant alerts
- Ratings calendar with rationale + price target
- Form 4 / 13D filings tagged to the issuer
- NVDA
Beats Q1 by $0.42; revenue guidance raised to $44.0–45.0B (above $42.8B consensus)
Data center revenue up 78% YoY; Blackwell ramp ahead of plan; CFO calls supply constraint resolved by Q3.
EARNINGSGUIDANCE12s ago - PFE
Acquires Acme Therapeutics for $3.4B; $46/share cash, expected close Q3 2026
Adds late-stage oncology pipeline; CEO expects accretion in 2027. Deal subject to shareholder vote.
M&A1m ago - TSLA
Downgraded to Sell at Wells Fargo; price target cut to $120 from $180
Cites margin pressure from China price competition and slower-than-expected energy storage ramp.
ANALYST4m ago - META
Authorizes additional $50B share buyback; expands existing $30B program
Reiterates capex guidance of $94–98B for 2026; AI infrastructure spend tracking to plan.
CAPITAL11m ago
One plan. Everything included.
Annual saves you two months. Either way, 14 days free — $0 today, charged after the trial unless you cancel.
- Real-time feed across 70+ wires
- AI-summarized headlines + ticker tags
- Earnings calendar with surprise + YoY
- Watchlist + per-ticker alerts
- Ratings page + analyst-action calendar
$0 today · Card on file required · Cancel anytime before charge
Start trading with the edge.
Fourteen days of full access. $0 today — charged after 14 days unless you cancel. See your first signal within seconds.
Start free trial →